We are live on
!
Find out more
CIP
Convergence Investment Partners Portfolio holdings
AUM
$1.06B
1-Year Est. Return
87.75%
This Fund
S&P 500
This Quarter
Est. Return
+8.47%
1 Year Est. Return
+87.75%
3 Year Est. Return
+284.26%
5 Year Est. Return
+379.02%
10 Year Est. Return
+1,390.46%
AUM
$678M
AUM Growth
-$48.9M
(-6.7%)
Cap. Flow
-$82.3M
Cap. Flow
% of AUM
-12.14%
Top 10 Holdings %
Top 10 Hldgs %
12.63%
Holding
435
New
127
Increased
76
Reduced
120
Closed
111
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$6.36M |
| 2 |
AT&T
T
|
+$6.07M |
| 3 |
CATM
Cardtronics plc Class A Ordinary Shares (UK)
CATM
|
+$5.04M |
| 4 |
CVG
Convergys
CVG
|
+$4.73M |
| 5 |
GXP
Great Plains Energy Incorporated
GXP
|
+$4.55M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Leidos
LDOS
|
+$5.48M |
| 2 |
RAX
Rackspace Hosting Inc
RAX
|
+$5.32M |
| 3 |
DYN
Dynegy, Inc.
DYN
|
+$5.03M |
| 4 |
Gilead Sciences
GILD
|
+$4.77M |
| 5 |
Verizon
VZ
|
+$4.76M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.1% |
| 2 | Technology | 13.84% |
| 3 | Industrials | 12.51% |
| 4 | Healthcare | 11.57% |
| 5 | Consumer Discretionary | 9.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
Huntington Ingalls Industries
HII
$12.8B
| $563K | 0.08% |
+3,667
| New | +$608K |
|
|
ESV
277
DELISTED
Ensco Rowan plc
ESV
| $561K | 0.08% |
+16,506
| New | +$562K |
|
278
Delek US
DK
$3.58B
| $556K | 0.08% |
+32,147
| New | +$493K |
|
|
CIVI
279
DELISTED
Civitas Solutions, Inc.
CIVI
| $555K | 0.08% |
30,414
-36,114
| -54% | -$715K |
|
|
SN
280
DELISTED
Sanchez Energy Corporation
SN
| $552K | 0.08% |
+62,483
| New | +$481K |
|
281
Cleveland-Cliffs
CLF
$6.99B
| $534K | 0.08% |
+91,263
| New | +$596K |
|
|
INSY
282
DELISTED
Insys Therapeutics, Inc.
INSY
| $529K | 0.08% |
44,905
+28,940
| +181% | +$440K |
|
283
Oshkosh
OSK
$9.59B
| $523K | 0.08% |
9,341
-3,152
| -25% | -$166K |
|
|
JNS
284
DELISTED
Janus Capital Group Inc
JNS
| $515K | 0.08% |
+36,766
| New | +$532K |
|
285
Alphabet (Google) Class A
GOOGL
$4.33T
| $489K | 0.07% |
12,160
-2,200
| -15% | -$86K |
|
|
PRXL
286
DELISTED
Parexel International Corp
PRXL
| $487K | 0.07% |
+7,011
| New | +$473K |
|
287
Ezcorp Inc
EZPW
$1.71B
| $482K | 0.07% |
+43,595
| New | +$421K |
|
288
Abercrombie & Fitch
ANF
$5B
| $477K | 0.07% |
+30,009
| New | +$580K |
|
289
World Acceptance Corp
WRLD
$873M
| $476K | 0.07% |
9,711
-4,590
| -32% | -$220K |
|
290
Exelixis
EXEL
$13.4B
| $475K | 0.07% |
+37,160
| New | +$402K |
|
291
HNI Corp
HNI
$3.59B
| $472K | 0.07% |
+11,870
| New | +$601K |
|
|
BID
292
DELISTED
Sotheby's
BID
| $472K | 0.07% |
+12,426
| New | +$439K |
|
293
NOV
NOV
$7B
| $462K | 0.07% |
12,566
-55,041
| -81% | -$1.85M |
|
|
MANT
294
DELISTED
Mantech International Corp
MANT
| $462K | 0.07% |
12,267
-38,065
| -76% | -$1.51M |
|
295
Amazon
AMZN
$2.96T
| $430K | 0.06% |
10,280
-1,780
| -15% | -$68.1K |
|
296
Brookdale Senior Living
BKD
$3.4B
| $427K | 0.06% |
+24,493
| New | +$422K |
|
297
Globus Medical
GMED
$11.2B
| $416K | 0.06% |
+18,417
| New | +$433K |
|
|
VR
298
DELISTED
Validus Hold Ltd
VR
| $384K | 0.06% |
7,705
-9,372
| -55% | -$466K |
|
299
UnitedHealth
UNH
$370B
| $358K | 0.05% |
2,557
-25
| -1% | -$3.5K |
|
300
First Bancorp
FBP
$4.38B
| $310K | 0.05% |
+59,533
| New | +$275K |
|
Similar funds
MWA
SFP
ECM
NRG
HW
LAM
BGIM
CIA
Convergence Investment Partners's Q3 2016 Portfolio in Review
As of Q3 2016, Convergence Investment Partners held 435 positions worth $678M, down 6.7% from $727M the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Convergence Investment Partners withdrew a net $82.3M in Q3 2016, closing 111 positions and reducing 120 holdings. Its most notable exit was Leidos, an estimated $5.48M position sold in full.
By sector, the portfolio is most concentrated in Financials at 16% of assets, up from 16% a quarter earlier, followed by Technology and Industrials.
Against the trend, Convergence Investment Partners opened a new position in Cardtronics plc Class A Ordinary Shares (UK) worth $5.11M.
- Convergence Investment Partners's largest Q3 2016 buy was Cardtronics plc Class A Ordinary Shares (UK): 114,485 shares worth $5.11M.
- Convergence Investment Partners added most to Pfizer in Q3 2016, an estimated $6.36M increase.
- Convergence Investment Partners's biggest Q3 2016 reduction was Gilead Sciences, cutting an estimated $4.77M.
- Convergence Investment Partners fully exited Leidos in Q3 2016, selling an estimated $5.48M.
- Convergence Investment Partners's ten largest holdings make up 13% of its $678M portfolio in Q3 2016.
- Convergence Investment Partners opened 127 new positions and closed 111 in Q3 2016.
- Convergence Investment Partners's portfolio value fell 6.7% quarter-over-quarter to $678M.
Based on Convergence Investment Partners's 13F filing for Q3 2016, filed 10 Nov 2016.